Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.

Peetermans M, Liesenborghs L, Peerlinck K, Wijngaerden EV, Gheysens O, Goffin KE, Hoylaerts MF, Jacquemin M, Verhaegen J, Peetermans WE, Verhamme P, Vanassche T; Staphylothrombin Investigators.

Thromb Haemost. 2018 May;118(5):818-829. doi: 10.1055/s-0038-1639586. Epub 2018 Apr 3.

PMID:
29614521
2.

An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.

Roose E, Schelpe AS, Joly BS, Peetermans M, Verhamme P, Voorberg J, Greinacher A, Deckmyn H, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K.

J Thromb Haemost. 2018 Feb;16(2):378-388. doi: 10.1111/jth.13922. Epub 2018 Jan 23.

PMID:
29222940
3.

Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall.

Claes J, Liesenborghs L, Peetermans M, Veloso TR, Missiakas D, Schneewind O, Mancini S, Entenza JM, Hoylaerts MF, Heying R, Verhamme P, Vanassche T.

J Thromb Haemost. 2017 May;15(5):1009-1019. doi: 10.1111/jth.13653. Epub 2017 Mar 23.

PMID:
28182324
4.

Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose".

Peetermans M, Verhamme P.

Clin Toxicol (Phila). 2017 Jan;55(1):66. doi: 10.1080/15563650.2016.1240805. Epub 2016 Oct 14. No abstract available.

PMID:
27737559
5.

Idarucizumab for dabigatran overdose.

Peetermans M, Pollack C Jr, Reilly P, Liesenborghs L, Jacquemin M, Levy JH, Weitz JI, Verhamme P.

Clin Toxicol (Phila). 2016 Sep;54(8):644-6. doi: 10.1080/15563650.2016.1187737. Epub 2016 May 25.

PMID:
27224445
6.

Shear-Resistant Binding to von Willebrand Factor Allows Staphylococcus lugdunensis to Adhere to the Cardiac Valves and Initiate Endocarditis.

Liesenborghs L, Peetermans M, Claes J, Veloso TR, Vandenbriele C, Criel M, Lox M, Peetermans WE, Heilbronner S, de Groot PG, Vanassche T, Hoylaerts MF, Verhamme P.

J Infect Dis. 2016 Apr 1;213(7):1148-56. doi: 10.1093/infdis/jiv773. Epub 2016 Jan 6.

PMID:
26743845
7.

Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation.

Kwiecinski J, Na M, Jarneborn A, Jacobsson G, Peetermans M, Verhamme P, Jin T.

Appl Environ Microbiol. 2015 Oct 30;82(1):394-401. doi: 10.1128/AEM.02803-15. Print 2016 Jan 1.

8.

Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity.

Peetermans M, Vanassche T, Liesenborghs L, Lijnen RH, Verhamme P.

Crit Rev Microbiol. 2016 Nov;42(6):866-82. doi: 10.3109/1040841X.2015.1080214. Epub 2015 Oct 20. Review.

PMID:
26485450
9.

The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.

Jacquemin M, Toelen J, Schoeters J, van Horenbeeck I, Vanlinthout I, Debasse M, Peetermans M, Vanassche T, Peerlinck K, van Ryn J, Verhamme P.

J Thromb Haemost. 2015 Nov;13(11):2087-92. doi: 10.1111/jth.13138. Epub 2015 Oct 5.

10.

Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists.

De Crem N, Peerlinck K, Vanassche T, Vanheule K, Debaveye B, Middeldorp S, Verhamme P, Peetermans M.

Thromb Res. 2015 Oct;136(4):749-53. doi: 10.1016/j.thromres.2015.07.030. Epub 2015 Aug 4.

PMID:
26272306
11.

Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation.

Kwiecinski J, Peetermans M, Liesenborghs L, Na M, Björnsdottir H, Zhu X, Jacobsson G, Johansson BR, Geoghegan JA, Foster TJ, Josefsson E, Bylund J, Verhamme P, Jin T.

J Infect Dis. 2016 Jan 1;213(1):139-48. doi: 10.1093/infdis/jiv360. Epub 2015 Jul 1.

PMID:
26136471
12.

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions.

Claes J, Liesenborghs L, Lox M, Verhamme P, Vanassche T, Peetermans M.

J Vis Exp. 2015 Jun 11;(100):e52862. doi: 10.3791/52862.

13.

Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?

Peetermans M, Verhamme P, Vanassche T.

Semin Thromb Hemost. 2015 Jun;41(4):433-44. doi: 10.1055/s-0035-1549849. Epub 2015 May 14. Review.

PMID:
25973589
14.

Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.

Peetermans M, Vanassche T, Liesenborghs L, Claes J, Vande Velde G, Kwiecinksi J, Jin T, De Geest B, Hoylaerts MF, Lijnen RH, Verhamme P.

BMC Microbiol. 2014 Dec 17;14:310. doi: 10.1186/s12866-014-0310-7.

15.

Monitoring and reversal strategies for new oral anticoagulants.

Vanden Daelen S, Peetermans M, Vanassche T, Verhamme P, Vandermeulen E.

Expert Rev Cardiovasc Ther. 2015 Jan;13(1):95-103. doi: 10.1586/14779072.2015.987126. Epub 2014 Nov 28. Review.

PMID:
25431993
16.

Active PAI-1 as marker for venous thromboembolism: case-control study using a comprehensive panel of PAI-1 and TAFI assays.

Bollen L, Peetermans M, Peeters M, Van Steen K, Hoylaerts MF, Declerck PJ, Verhamme P, Gils A.

Thromb Res. 2014 Nov;134(5):1097-102. doi: 10.1016/j.thromres.2014.08.007. Epub 2014 Aug 20.

PMID:
25193405
17.

IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease.

Peetermans M, Goeminne P, De Boeck C, Dupont LJ.

Chest. 2014 Sep;146(3):e99-e100. doi: 10.1378/chest.14-0635. No abstract available.

PMID:
25180753
18.

Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein.

Claes J, Vanassche T, Peetermans M, Liesenborghs L, Vandenbriele C, Vanhoorelbeke K, Missiakas D, Schneewind O, Hoylaerts MF, Heying R, Verhamme P.

Blood. 2014 Sep 4;124(10):1669-76. doi: 10.1182/blood-2014-02-558890. Epub 2014 Jun 20.

19.

Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation.

Vandenbriele C, Vanassche T, Peetermans M, Verhamme P, Peerlinck K.

J Thromb Thrombolysis. 2014 Jul;38(1):121-3. doi: 10.1007/s11239-013-1024-7.

PMID:
24202701
20.

The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections.

Vanassche T, Peetermans M, Van Aelst LN, Peetermans WE, Verhaegen J, Missiakas DM, Schneewind O, Hoylaerts MF, Verhamme P.

J Infect Dis. 2013 Jul;208(1):92-100. doi: 10.1093/infdis/jit130. Epub 2013 Mar 26.

PMID:
23532100
21.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial.

Labar B, Suciu S, Zittoun R, Muus P, Marie JP, Fillet G, Peetermans M, Stryckmans P, Willemze R, Feremans W, Jaksic B, Bourhis JH, Burghouts JP, de Witte T; EORTC Leukemia Group.

Haematologica. 2004 Jul;89(7):809-17.

22.

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.

Boogaerts M, Maertens J, van Hoof A, de Bock R, Fillet G, Peetermans M, Selleslag D, Vandercam B, Vandewoude K, Zachée P, De Beule K.

J Antimicrob Chemother. 2001 Jul;48(1):97-103.

23.

Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.

Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.

Semin Oncol. 2000 Apr;27(2 Suppl 5):52-7.

PMID:
10877053
24.

Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.

Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.

Ann Oncol. 1999 Dec;10(12):1493-8.

PMID:
10643542
25.

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial.

Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R.

Bone Marrow Transplant. 1997 Aug;20(4):307-15.

27.

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

Zittoun R, Suciu S, Mandelli F, de Witte T, Thaler J, Stryckmans P, Hayat M, Peetermans M, Cadiou M, Solbu G, Petti MC, Willemze R.

J Clin Oncol. 1996 Jul;14(7):2150-9.

PMID:
8683249
30.

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells.

Snoeck HW, Van Bockstaele DR, Nys G, Lenjou M, Lardon F, Haenen L, Rodrigus I, Peetermans ME, Berneman ZN.

J Exp Med. 1994 Sep 1;180(3):1177-82.

32.

Effect of retinoic acid (RA) on myeloid progenitors in normal bone marrow (BM)

Van Bockstaele DR, Lenjou M, Snoeck HW, Lardon F, Peetermans ME.

Leukemia. 1994 Jan;8(1):214-5. No abstract available.

PMID:
8289492
33.
34.

Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.

Snoeck HW, Lardon F, Lenjou M, Nys G, Van Bockstaele DR, Peetermans ME.

Exp Hematol. 1993 Oct;21(11):1480-6.

PMID:
7691636
36.
37.
38.

Effects of interleukin-4 (IL4) on myelopoiesis: studies on highly purified CD34+ hematopoietic progenitor cells.

Snoeck HW, Lardon F, van Bockstaele DR, Peetermans ME.

Leukemia. 1993 Apr;7(4):625-9.

PMID:
7681919
40.

Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells.

van Bockstaele DR, Lenjou M, Snoeck HW, Lardon F, Stryckmans P, Peetermans ME.

Ann Hematol. 1993 Feb;66(2):61-6.

PMID:
7680579
41.

Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity.

de Bock R, de Jonge M, Korthout M, Wouters E, van Bockstaele D, van der Planken M, Peetermans M.

Ann Hematol. 1992 Dec;65(6):247-52.

PMID:
1457585
42.

Reactions to platelet transfusion: the effect of the storage time of the concentrate.

Muylle L, Wouters E, De Bock R, Peetermans ME.

Transfus Med. 1992 Dec;2(4):289-93.

PMID:
1339583
43.

The effect of vancomycin and teicoplanin on normal human bone marrow progenitor cells.

de Bock R, Van Bockstaele D, Snoeck H, Lardon F, Peetermans M.

J Antimicrob Chemother. 1992 Oct;30(4):559-60. No abstract available.

PMID:
1490928
44.

BrdU-Hoechst-ethidium bromide (EB) quenching technique for studying kinetics of hematopoiesis.

Van Bockstaele DR, Lardon F, Snoeck HW, Peetermans ME, Kubbies M.

Blood. 1992 Jul 1;80(1):289-91. No abstract available.

45.

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative Group.

Willemze R, van der Lely N, Zwierzina H, Suciu S, Solbu G, Gerhartz H, Labar B, Visani G, Peetermans ME, Jacobs A, et al.

Ann Hematol. 1992 Apr;64(4):173-80. Erratum in: Ann Hematol 1992 Jun;64(6):312.

PMID:
1581405
46.

Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.

Stryckmans P, De Witte T, Marie JP, Fillet G, Peetermans M, Bury J, Muus P, Andrien JM, Hayat M, Jaksic B, et al.

Leukemia. 1992;6 Suppl 2:199-203. No abstract available.

PMID:
1578934
47.

Stromal populations and fibrosis in human long-term bone marrow cultures.

Chen ZZ, Van Bockstaele DR, Buyssens N, Hendrics D, De Meester I, Vanhoof G, Scharpé SL, Peetermans ME, Berneman ZN.

Leukemia. 1991 Sep;5(9):772-81.

PMID:
1658497
48.

Aberrant Ki-67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis.

Van Bockstaele DR, Lan J, Snoeck HW, Korthout ML, De Bock RF, Peetermans ME.

Cytometry. 1991;12(1):50-63.

49.

Flow-cytometric analysis of erythrocytic blood group A antigen density profile.

Berneman ZN, van Bockstaele DR, Uyttenbroeck WM, Van Zaelen C, Cole-Dergent J, Muylle L, Peetermans ME.

Vox Sang. 1991;61(4):265-74.

PMID:
1776244
50.

Pulmonary aspergillosis complicated by osteomyelitis.

De Bock R, Schrijvers D, Peetermans M.

Acta Clin Belg. 1991;46(6):397-400.

PMID:
1665943

Supplemental Content

Loading ...
Support Center